-
Product Insights
Block CI-27 Complex Field, Cote d’Ivoire
Block CI-27 Complex upstream field is located in Gulf of Guinea, Cote d'Ivoire. The upstream field is owned by Energie De Cote D’Ivoire SA (12%); Foxtrot International LDC (24%); Petroci Gaz (40%); Saur Energie Cote D'Ivoire (24%). It is operated by Foxtrot International LDC. The project started its operations in 1999. Block CI-27 Complex Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as...
-
Product Insights
Ci Medical – Nomi Logistics Center – Ishikawa
Equip yourself with the essential tools needed to make informed and profitable decisions with our Ci Medical - Nomi Logistics Center - Ishikawa report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Castlebrooke Inv – CIS Tower Expansion – Manchester
Equip yourself with the essential tools needed to make informed and profitable decisions with our Castlebrooke Inv - CIS Tower Expansion - Manchester report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Magnezit Grp – CIS Industrial Complex – Krasnoyarskiy
Equip yourself with the essential tools needed to make informed and profitable decisions with our Magnezit Grp - CIS Industrial Complex - Krasnoyarskiy report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
ANEEL – Dianopolis II – Palmas CI Transmission Line – Tocantins
Equip yourself with the essential tools needed to make informed and profitable decisions with our ANEEL - Dianopolis II - Palmas CI Transmission Line - Tocantins report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
ANEEL – Dianopolis II – Gurupi CI Transmission Line – Tocantins
Equip yourself with the essential tools needed to make informed and profitable decisions with our ANEEL - Dianopolis II - Gurupi CI Transmission Line - Tocantins report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Luossavaara-Kiirunavaara/ Nysno CI/ REEtec – Heroya Industrial Production Plant – Telemark
Equip yourself with the essential tools needed to make informed and profitable decisions with our Luossavaara-Kiirunavaara/ Nysno CI/ REEtec - Heroya Industrial Production Plant - Telemark report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Company Profile
![]()
CI Financial Corp – Company Profile
CI Financial Corp (CI) is a diversified wealth management firm and an independent investment fund company. It manages, markets, administers and distributes financial products and services. Its products include mutual funds, exchange-traded funds, segregated funds, financial planning, insurance, investment advice, wealth management, distribution of securities, and estate and succession planning. CI distributes its products through insurance advisors, brokers, and independent financial planners. The company along with its subsidiaries operates in Canada, the US, and Australia. CI is headquartered in Toronto,...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EG-501 in Cognitive Impairment
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.EG-501 in Cognitive ImpairmentDrug Details:EG-501 is under development for the treatment of cognitive impairment (CI) in...
-
Product Insights
Lion-Panthere Field, Cote d’Ivoire
Lion-Panthere upstream field is located in Gulf of Guinea, Cote d'Ivoire. The upstream field is owned by Compagnie Ivoirienne Du Petrole et Des Mines SA (26.90%); PETROCI CI-11 Ltd (47.96%); Petroci Gaz (20.14%); Unspecified Company (5%). It is operated by PETROCI CI-11 Ltd. The project started its operations in 1994. Lion-Panthere Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EG-501 in Systemic Lupus Erythematosus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EG-501 in Systemic Lupus Erythematosus Drug Details:EG-501 is under development for the treatment of cognitive impairment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CC-4066 in Acute Renal Failure (ARF) (Acute Kidney Injury)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CC-4066 in Acute Renal Failure (ARF) (Acute Kidney Injury)Drug Details:CC-4066 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ICIP in Metastatic Breast Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ICIP in Metastatic Breast Cancer Drug Details: iCIP is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AB-248 in Metastatic Melanoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AB-248 in Metastatic Melanoma Drug Details:AB-248 is under development for the treatment of locally advanced or...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Nadofaragene Firadenovec in Malignant Pleural Mesothelioma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Nadofaragene Firadenovec in Malignant Pleural Mesothelioma Drug Details: Nadofaragene firadenovec (Adstiladrin)Â is a non-replicating adenoviral vector-based...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Icip in Skin Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ICIP in Skin Cancer Drug Details: iCIP is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Icip in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ICIP in Solid Tumor Drug Details: iCIP is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Imiquimod in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Imiquimod in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Drug Details:Imiquimod is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BPC-1 in Metastatic Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BPC-1 in Metastatic Breast Cancer Drug Details:BPC-1 is under development for the treatment of metastatic breast...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AB-248 in Head And Neck Cancer Squamous Cell Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AB-248 in Head And Neck Cancer Squamous Cell Carcinoma Drug Details:AB-248 is under development for the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.